Exosomal MiRNAs-a Diagnostic Biomarker Acting As a Guiding Light in the Diagnosis of Prostate Cancer

Overview

Journal Funct Integr Genomics

Publisher Springer

Specialties Genetics
Molecular Biology

Date 2022 Dec 27

PMID 36574059

Authors

Sougata Ghosh Chowdhury

Rachayeeta Ray

Parimal Karmakar

Affiliations

Soon will be listed here.

Abstract

Prostate cancer, one of the major causes of mortality globally is regarded as the second leading cause of mortality among men. It is known to affect the stromal cells surrounding it. Through the use of exosomes, the affected stromal cells can promote the growth and spread of the cancer. Exosomes are known to play a role not only in the development and progression of cancer but also contribute to the drug-resistance character of cancer cells. Recently, the discovery of the small non-coding RNAs or miRNA has attracted attention of cancer researchers as they can regulate the expression of different genes. Therefore, exosomal miRNA can be used as a novel and reliable biomarker for the diagnosis and treatment of prostate cancer. In addition, exosomal miRNAs can also be used as a potential treatment for prostate cancer. The goal of this review is to provide a comprehensive analysis of the current knowledge about the role of exosomal miRNAs in the treatment of patients with prostate cancer and their potential role in monitoring the disease.

Citing Articles

Targeting the autophagy-miRNA axis in prostate cancer: toward novel diagnostic and therapeutic strategies.

Syed R, Alshammari M, Banu H, Khojali W, Jafar M, Nagaraju P Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(10):7421-7437.

PMID: 38761210 DOI: 10.1007/s00210-024-03153-0.

Dumbbell Dual-Hairpin Triggered DNA Nanonet Assembly for Cascade-Amplified Sensing of Exosomal MicroRNA.

Li Y, Tang X, Deng R, Feng L, Xie S, Chen M ACS Omega. 2024; 9(17):19723-19731.

PMID: 38708273 PMC: 11064005. DOI: 10.1021/acsomega.4c02652.

miR-3133 is an unfavorable prognosis factor and tumor suppressor in colon cancer.

Gao H, Zhang C Funct Integr Genomics. 2023; 23(2):132.

PMID: 37079151 DOI: 10.1007/s10142-023-01059-3.

Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers.

Rao Bommi J, Kummari S, Lakavath K, Sukumaran R, Panicker L, Marty J Biosensors (Basel). 2023; 13(3).

PMID: 36979610 PMC: 10046866. DOI: 10.3390/bios13030398.

References

Akoto T, Saini S . Role of Exosomes in Prostate Cancer Metastasis. Int J Mol Sci. 2021; 22(7). PMC: 8036381. DOI: 10.3390/ijms22073528. View

Alcayaga-Miranda F, Gonzalez P, Lopez-Verrilli A, Varas-Godoy M, Aguila-Diaz C, Contreras L . Prostate tumor-induced angiogenesis is blocked by exosomes derived from menstrual stem cells through the inhibition of reactive oxygen species. Oncotarget. 2016; 7(28):44462-44477. PMC: 5190111. DOI: 10.18632/oncotarget.9852. View

Azmi A, Bao B, Sarkar F . Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 2013; 32(3-4):623-42. PMC: 3843988. DOI: 10.1007/s10555-013-9441-9. View

Banerjee S, Thompson W, Chowdhury I . Emerging roles of microRNAs in the regulation of Toll-like receptor (TLR)-signaling. Front Biosci (Landmark Ed). 2020; 26(4):771-796. PMC: 9550351. DOI: 10.2741/4917. View

Bertoli G, Cava C, Castiglioni I . MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer. Int J Mol Sci. 2016; 17(3):421. PMC: 4813272. DOI: 10.3390/ijms17030421. View

Bhagirath D, Yang T, Bucay N, Sekhon K, Majid S, Shahryari V . microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer. Cancer Res. 2018; 78(7):1833-1844. PMC: 5890910. DOI: 10.1158/0008-5472.CAN-17-2069. View

Bhome R, Del Vecchio F, Lee G, Bullock M, Primrose J, Sayan A . Exosomal microRNAs (exomiRs): Small molecules with a big role in cancer. Cancer Lett. 2018; 420:228-235. PMC: 5831981. DOI: 10.1016/j.canlet.2018.02.002. View

Bryant R, Pawlowski T, Catto J, Marsden G, Vessella R, Rhees B . Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer. 2012; 106(4):768-74. PMC: 3322952. DOI: 10.1038/bjc.2011.595. View

Bucay N, Sekhon K, Yang T, Majid S, Shahryari V, Hsieh C . MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer. Oncogene. 2016; 36(19):2667-2679. PMC: 5426972. DOI: 10.1038/onc.2016.419. View

10.

Che Y, Shi X, Shi Y, Jiang X, Ai Q, Shi Y . Exosomes Derived from miR-143-Overexpressing MSCs Inhibit Cell Migration and Invasion in Human Prostate Cancer by Downregulating TFF3. Mol Ther Nucleic Acids. 2019; 18:232-244. PMC: 6796755. DOI: 10.1016/j.omtn.2019.08.010. View

11.

Chen Q, Zhao X, Zhang H, Yuan H, Zhu M, Sun Q . MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2. Mol Carcinog. 2014; 54(11):1292-300. DOI: 10.1002/mc.22204. View

12.

Chu H, Chen Y, Yuan Q, Hua Q, Zhang X, Wang M . The HOTAIR, PRNCR1 and POLR2E polymorphisms are associated with cancer risk: a meta-analysis. Oncotarget. 2017; 8(26):43271-43283. PMC: 5522144. DOI: 10.18632/oncotarget.14920. View

13.

Condrat C, Thompson D, Barbu M, Bugnar O, Boboc A, Cretoiu D . miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis. Cells. 2020; 9(2). PMC: 7072450. DOI: 10.3390/cells9020276. View

14.

Corcoran C, Rani S, ODriscoll L . miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression. Prostate. 2014; 74(13):1320-34. DOI: 10.1002/pros.22848. View

15.

Dilsiz N . Role of exosomes and exosomal microRNAs in cancer. Future Sci OA. 2020; 6(4):FSO465. PMC: 7117563. DOI: 10.2144/fsoa-2019-0116. View

16.

Druz A, Chen Y, Guha R, Betenbaugh M, Martin S, Shiloach J . Large-scale screening identifies a novel microRNA, miR-15a-3p, which induces apoptosis in human cancer cell lines. RNA Biol. 2013; 10(2):287-300. PMC: 3594287. DOI: 10.4161/rna.23339. View

17.

Duca R, Massillo C, Dalton G, Farre P, Grana K, Gardner K . MiR-19b-3p and miR-101-3p as potential biomarkers for prostate cancer diagnosis and prognosis. Am J Cancer Res. 2021; 11(6):2802-2820. PMC: 8263646. View

18.

El Bezawy R, Tinelli S, Tortoreto M, Doldi V, Zuco V, Folini M . miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition. J Exp Clin Cancer Res. 2019; 38(1):51. PMC: 6360656. DOI: 10.1186/s13046-019-1060-z. View

19.

Ell B, Kang Y . MicroRNAs as regulators of bone homeostasis and bone metastasis. Bonekey Rep. 2014; 3:549. PMC: 4119205. DOI: 10.1038/bonekey.2014.44. View

20.

Fabbri M . MicroRNAs and miRceptors: a new mechanism of action for intercellular communication. Philos Trans R Soc Lond B Biol Sci. 2017; 373(1737). PMC: 5717440. DOI: 10.1098/rstb.2016.0486. View